- 全部删除
您的购物车当前为空
TC-MCH 7c 是一种可口服的、可选择的、可穿透血脑屏障的MCH1R 拮抗剂,其对hMCH1R 的IC50表现为5.6 nM,TC-MCH 7c 是一种苯基吡啶酮衍生物,其对人的MCH1R Ki 分别为 3.4 nM ,对小鼠 MCH1R Ki 为 3.0 nM。


为众多的药物研发团队赋能,
让新药发现更简单!
TC-MCH 7c 是一种可口服的、可选择的、可穿透血脑屏障的MCH1R 拮抗剂,其对hMCH1R 的IC50表现为5.6 nM,TC-MCH 7c 是一种苯基吡啶酮衍生物,其对人的MCH1R Ki 分别为 3.4 nM ,对小鼠 MCH1R Ki 为 3.0 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 966 | In stock | |
| 5 mg | ¥ 2,370 | In stock | |
| 10 mg | ¥ 3,450 | In stock | |
| 25 mg | ¥ 5,290 | In stock | |
| 50 mg | ¥ 7,140 | In stock | |
| 100 mg | ¥ 9,480 | In stock | |
| 500 mg | ¥ 19,100 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,690 | In stock |
TC-MCH 7c 相关产品
| 产品描述 | TC-MCH 7c is an oral, selectable and blood-brain barrier penetrating MCH1R antagonist with IC50 performance of 5.6 nM against hMCH1R, and TC-MCH 7c is a phenylpyridone derivative with MCH1R Ki of 3.4 nM against human. In mice, MCH1R Ki was 3.0 nM. |
| 靶点活性 | MCH1R (human):5.6 nM , MCH1R (mouse):3.0 nM , MCH1R (human):3.4 nM (ki), MCH1R (human):(ki)3.4 nM , MCH1R (mouse):3.0 nM, MCH1R (human):5.6 nM |
| 体外活性 | 在[Ca2+]i动员活动中,TC-MCH 7c对MCH1R的IC50为9.7 μM [1]。TC-MCH 7c对FLIPR的IC50为23 nM,而对hERG的IC50为9.0 μM [2]。 |
| 体内活性 | 在DIO小鼠模型中,TC-MCH 7c(口服;3-30 mg/kg;每日一次,连续1.5个月)能够呈现出优异的剂量依赖性体重降低效果[1]。TC-MCH 7c(口服;3至30mg/kg)在2小时、15小时和24小时的浓度分别为5.1、1.8和0.7 μM[2]。 |
| 分子量 | 408.47 |
| 分子式 | C24H25FN2O3 |
| CAS No. | 864756-35-4 |
| Smiles | Fc1ccc(COc2ccn(-c3ccc(OCCN4CCCC4)cc3)c(=O)c2)cc1 |
| 密度 | 1.27 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 55 mg/mL (134.65 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容